Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-4800 COVID-19 Vaccine Trial in Healthy Volunteers
NCT04447781Phase 2Completed
- Sponsor
- International Vaccine Institute
- Start
- Jul 2020
- Primary completion
- Jul 2021
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of INO-4800 in coronavirus disease 2019 (COVID-19), sponsored by International Vaccine Institute. Started Jul 2020; status: completed.
02
Drugs
INO-4800
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04447781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447781.